Suppr超能文献

[局部晚期胰腺癌患者动脉内灌注化疗与根治性胰切除术的评估]

[Evaluation of intra-arterial infusion chemotherapy and radical pancreatectomy in patients with locally advanced pancreatic cancer].

作者信息

Ohigashi H, Ishikawa O, Nakamori S, Sasaki Y, Masutani S, Kameyama M, Hiratsuka M, Kabuto T, Furukawa H, Imaoka S

机构信息

Dept. of Surgery, Center for Adult Diseases, Osaka.

出版信息

Gan To Kagaku Ryoho. 1993 Aug;20(11):1672-5.

PMID:8373245
Abstract

This is a retrospective study to evaluate arterial infusion chemotherapy and resection for locally advanced pancreatic cancer involving retro-peritoneal organs or large vessels such as superior mesenteric artery or celiac trunks. Intra-arterial chemotherapy was performed for 19 patients, and 15 underwent pancreatectomy. Patients in the intra-arterial chemotherapy group could live 11 months out of the hospital, against 4 months in the resected cases (p < 0.05). The period of over 2nd degree in performance status was 11 months in the arterial chemotherapy group and 3 months in resected groups (p < 0.05). The survival rates were 53, 18 and 9% at 1, 2 and 3 years in the patients with arterial chemotherapy, respectively, against 22, 15 and 15% in the resected patients (p < 0.05). These results suggested that intra-arterial chemotherapy was significantly effective in prolonging the survival period with a better quality of life.

摘要

这是一项回顾性研究,旨在评估动脉灌注化疗及手术切除对累及腹膜后器官或诸如肠系膜上动脉或腹腔干等大血管的局部晚期胰腺癌的治疗效果。19例患者接受了动脉内化疗,其中15例接受了胰腺切除术。动脉内化疗组患者的院外生存时间为11个月,而手术切除组为4个月(p<0.05)。动脉化疗组患者体能状态超过2级的时间为11个月,手术切除组为3个月(p<0.05)。接受动脉化疗的患者1年、2年和3年生存率分别为53%、18%和9%,而手术切除患者分别为22%、15%和15%(p<0.05)。这些结果表明,动脉内化疗在延长生存期及改善生活质量方面具有显著疗效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验